AC T15312
XX
ID T15312
XX
DT 10.03.2005 (created); nvo.
DT 02.01.2015 (updated); msr.
CO Copyright (C), QIAGEN.
XX
FA c-Ets-2
XX
SY ETS-2; Ets2.
XX
OS Mammalia
OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia
XX
IN T11261 c-Rel; Mammalia.
IN T15118 CBP; Mammalia.
IN T10446 GR; Mammalia.
IN T09278 IRF-4-isoform1; mouse, Mus musculus.
IN T10890 Oct3; Mammalia.
IN T23091 p300; Mammalia.
XX
MX M07379 V$ETS2_Q4.
MX M01207 V$ETS2_Q6.
MX M08881 V$ETSLIKE_Q4.
MX M00340 V$ETS_B.
MX M00771 V$ETS_Q4.
MX M00971 V$ETS_Q6.
XX
BS R37835.
BS R62015.
BS R33315.
BS R26779.
BS R26780.
BS R18147.
BS R73908.
BS R12088.
BS R65547.
BS R26372.
BS R61443.
BS R61440.
BS R25719.
BS R61435.
BS R02924.
XX
DR TRANSPATH: MO000047322.
DR TRANSCOMPEL: C00079.
DR TRANSCOMPEL: C00080.
DR TRANSCOMPEL: C00082.
DR TRANSCOMPEL: C00083.
DR TRANSCOMPEL: C00084.
DR TRANSCOMPEL: C00085.
XX
RN [1]; RE0016555.
RX PUBMED: 9551977.
RA Perkel J. M., Atchison M. L.
RT A two-step mechanism for recruitment of Pip by PU.1
RL J. Immunol. 160:241-252 (1998).
RN [2]; RE0023549.
RX PUBMED: 11279115.
RA Mullick J., Anandatheerthavarada H. K., Amuthan G., Bhagwat S. V., Biswas G., Camasamudram V., Bhat N. K., Reddy S. E., Rao V., Avadhani N. G.
RT Physical interaction and functional synergy between glucocorticoid receptor and Ets2 proteins for transcription activation of the rat cytochrome P-450c27 promoter.
RL J. Biol. Chem. 276:18007-18017 (2001).
RN [3]; RE0034094.
RX PUBMED: 15240733.
RA Wei G., Guo J., Doseff A. I., Kusewitt D. F., Man A. K., Oshima R. G., Ostrowski M. C.
RT Activated Ets2 is required for persistent inflammatory responses in the motheaten viable model.
RL J. Immunol. 173:1374-9 (2004).
RN [4]; RE0035363.
RX PUBMED: 10749681.
RA Zhang W., Revers L., Pierce M., Schachter H.
RT Regulation of expression of the human beta-1,2-N-acetylglucosaminyltransferase II gene (MGAT2) by Ets transcription factors.
RL Biochem. J. 347:511-518 (2000).
RN [5]; RE0035591.
RX PUBMED: 10358095.
RA Jayaraman G., Srinivas R., Duggan C., Ferreira E., Swaminathan S., Somasundaram K., Williams J., Hauser C., Kurkinen M., Dhar R., Weitzman S., Buttice G., Thimmapaya B.
RT p300/cAMP-responsive element-binding protein interactions with ets-1 and ets-2 in the transcriptional activation of the human stromelysin promoter.
RL J. Biol. Chem. 274:17342-17352 (1999).
RN [6]; RE0036337.
RX PUBMED: 11822868.
RA Barradas M., Gonos E. S., Zebedee Z., Kolettas E., Petropoulou C., Delgado M. D., Leon J., Hara E., Serrano M.
RT Identification of a candidate tumor-suppressor gene specifically activated during Ras-induced senescence
RL Exp. Cell Res. 273:127-37 (2002).
RN [7]; RE0036383.
RX PUBMED: 11689681.
RA Ezashi T., Ghosh D., Roberts R. M.
RT Repression of Ets-2-induced transactivation of the tau interferon promoter by Oct-4
RL Mol. Cell. Biol. 21:7883-91 (2001).
RN [8]; RE0037489.
RX PUBMED: 12511603.
RA Ghosh D., Ezashi T., Ostrowski M. C., Roberts R. M.
RT A central role for Ets-2 in the transcriptional regulation and cyclic adenosine 5'-monophosphate responsiveness of the human chorionic gonadotropin-beta subunit gene
RL Mol. Endocrinol. 17:11-26 (2003).
RN [9]; RE0037965.
RX PUBMED: 10650939.
RA Greenland K. J., Jantke I., Jenatschke S., Bracken K. E., Vinson C., Gellersen B.
RT The human NAD+-dependent 15-hydroxyprostaglandin dehydrogenase gene promoter is controlled by Ets and activating protein-1 transcription factors and progesterone
RL Endocrinology 141:581-97 (2000).
RN [10]; RE0039436.
RX PUBMED: 11234019.
RA Ohtani N., Zebedee Z., Huot T. J., Stinson J. A., Sugimoto M., Ohashi Y., Sharrocks A. D., Peters G., Hara E.
RT Opposing effects of Ets and Id proteins on p16INK4a expression during cellular senescence
RL Nature 409:1067-70 (2001).
RN [11]; RE0042378.
RX PUBMED: 14722092.
RA Matsuda S., Harries J. C., Viskaduraki M., Troke P. J., Kindle K. B., Ryan C., Heery D. M.
RT A Conserved alpha-helical motif mediates the binding of diverse nuclear proteins to the SRC1 interaction domain of CBP
RL J. Biol. Chem. 279:14055-64 (2004).
RN [12]; RE0045343.
RX PUBMED: 9573048.
RA Yamamoto H., Flannery M. L., Kupriyanov S., Pearce J., McKercher S. R., Henkel G. W., Maki R. A., Werb Z., Oshima R. G.
RT Defective trophoblast function in mice with a targeted mutation of Ets2
RL Genes Dev. 12:1315-26 (1998).
RN [13]; RE0045352.
RX PUBMED: 11313931.
RA Kasten M., Giordano A.
RT Cdk10, a Cdc2-related kinase, associates with the Ets2 transcription factor and modulates its transactivation activity
RL Oncogene 20:1832-8 (2001).
RN [14]; RE0046930.
RX PUBMED: 14678752.
RA Wolvetang E. J., Bradfield O. M., Hatzistavrou T., Crack P. J., Busciglio J., Kola I., Hertzog P. J.
RT Overexpression of the chromosome 21 transcription factor Ets2 induces neuronal apoptosis
RL Neurobiol. Dis. 14:349-56 (2003).
RN [15]; RE0048238.
RX PUBMED: 11027273.
RA Smith J. L., Schaffner A. E., Hofmeister J. K., Hartman M., Wei G., Forsthoefel D., Hume D. A., Ostrowski M. C.
RT ets-2 is a target for an akt (Protein kinase B)/jun N-terminal kinase signaling pathway in macrophages of motheaten-viable mutant mice.
RL Mol. Cell. Biol. 20:8026-8034 (2000).
RN [16]; RE0048259.
RX PUBMED: 12894593.
RA Wei G., Schaffner A. E., Baker K. M., Mansky K. C., Ostrowski M. C.
RT Ets-2 interacts with co-repressor BS69 to repress target gene expression.
RL Anticancer Res. 23:2173-2178 (2003).
RN [17]; RE0054487.
RX PUBMED: 17027647.
RA Lim J. H., Cho J. Y., Park Y. B., Park J. W., Kwon T. K.
RT ESE-3 transcription factor is involved in the expression of death receptor (DR)-5 through putative Ets sites.
RL Biochem. Biophys. Res. Commun. 350:736-741 (2006).
XX
//